AZAbdukhakim Ziyaev

Abdukhakim Ziyaev

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Abdukhakim Ziyaev has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effect of Diphenyl-1,2,4-triazole-3-thione and Its Derivatives on the Volume Regulation System and Related Cellular Processes in Thymocytes

    by Umrbek J. Rizaqulov, Mukhriddin M. Mansurov, Gulnoza A. Toshtemirova, Lobar H. Fayzullaeva, Sarvinoz I. Rustamova, Diyor D. Fayziev, Abduhakim A. Ziyaev, Turdibek T. Toshmurodov, Bahrom N. Babaev, Ranokhon Sh. Kurbannazarova, et al.

    Triazole-containing drugs are widely used to treat cancer, fungal infections, anxiety, migraines, viral infections, and diabetes. Although different molecular targets have been identified for these compounds, their effects on the system of regulation of cellular volume and the underlying ion channels remain unexplored. In the present study, we address this important question by examining newly synthesized derivatives of 4,5-diphenyl-2H-1,2,4-triazole-3-thione (DPTT). Unmodified DPTT had the weakest effect on regulatory volume decrease (RVD) of osmotically swollen thymocytes. Introducing side chains at the sulfur atom increased RVD-inhibiting activity, which was maximal for the N,N-dibutylacetamide-derivative (compound 5) , which completely abolished thymocyte RVD with a concentration of half-maximal effect ( C 50 ) of 10.8 µM. In patch-clamp experiments, compound 5 blocked the volume-sensitive/volume-regulated anion channel (VSOR/VRAC) in a manner independent of the applied voltage with C 50 of ~14 µM. The substance suppressed the proliferation of thymocytes in primary culture and increased the proportion of PI-positive cells without a corresponding increase in annexin V-positive cells, suggesting predominantly membrane-compromising, non-apoptotic cell death. Similar C 50 values indicate an association consistent with a possible mechanistic relationship between ion channel blockage, RVD inhibition, and suppression of cell proliferation. The obtained data reveal a novel pharmacological activity of triazole derivatives that has not been considered before, mediated by ion channel modulation and targeting the machinery of regulation of cellular volume.

  • Open Access

    In vitro evaluation of 1,3,4-oxadiazolethiones for insecticidal activity in agricultural pest cell lines

    by S. Khasanov, A. Ziyaev, J. Abdurakhmanov, S. Sasmakov, T. Toshmurodov, A. Mardonov, S. Kadirova, O. Ashirov, S. Ikramov, S. Azimova, et al.

    The paper was dedicated to the investigation of the insecticidal activities of recently prepared 1,3,4-oxadiazole compounds and their in vitro efficacy was determined with the help of cell lines taken out of Helicoverpa zea, Trichoplusia ni and Lymantria dispar. The MTT assay yielded results that showed that the compounds synthesized had insecticidal activities between 88.4 -97.2 - 100 µM that were similar to those of the commercial insecticide Imidacloprid 2F of 96.4 -98.3 - 100 µM. In silico testing showed that the newly prepared compounds bind to a variety of amino acid residues either with several interaction modes at the same time such as π-π stacking, hydrogen bonding, π-π anion interaction, and π-π alkyl interaction, specifically against acetylcholinesterase (AChE) of the insect species used. Since they are relatively harmless to the environment, these 1,3,4-oxadiazole derivatives have a potential as alternative agents in sustainable pests control in agriculture, which could be beneficial compared to the use of conventional insecticides. The results highlight the effectiveness of such compounds as effective agents against insect cell lines in agriculture. However, in order to completely prove their practical implementation, there is a need to conduct additional in vivo research and field tests are suggested to verify their effectiveness in real-world situations.


  • Open Access

    Synthesis of S-(5-aryl-1,3,4-oxadiazol-2-yl) O-alkyl carbonothioate and alkyl 2-((5-aryl-1,3,4-oxadiazol-2-yl)thio) acetate, and their antimicrobial properties

    by Abdukhakim Zi̇yAev, Sobirdjan Sasmakov, Turdibek Toshmurodov, Mavluda Ziyaeva, Jaloliddin Abdurakhmanov, Shukhrat Khasanov, Shakhnoz Azi̇mOva

    The S-(5-aryl-1,3,4-oxadiazol-2-yl) O-alkyl carbonothioate (4-9) and the alkyl 2-((5-aryl-1,3,4-oxadiazol-2-yl)thio) acetate (10-15) were synthesized by interaction of 5-aryl-1,3,4-oxadiazole-2-thiones with alkyl esters of chloroformic acid and chloroacetic acid. The yields of target compounds (7-9) obtained with isobutyl chloroformate were 69-73%, compounds (4-6) with propyl chloroformate - 74-79% and compounds (10-15) with alkyl esters of chloroacetic acid - 86-92%, respectively. The structures of the synthesized compounds were confirmed by IR, UV, 1H and 13C NMR spectra. The antibacterial and antifungal activities of these compounds were investigated. The results of in vitro antimicrobial activity tests showed that S-(5-phenyl(2-chlorophenyl)-1,3,4-oxadiazol-2-yl) O-propyl carbonothioate (4-5) and S-(5-phenyl(2-chlorophenyl)-1,3,4-oxadiazol-2-yl) O-isobutyl carbonothioate (7-8) exhibited weak, but selective antibacterial activity against gram-positive bacteria (Bacillus subtilis and Staphylococcus aureus). At the same time, no activity was shown by compounds with two chlorine atoms in the aromatic ring (13-15) and alkyl 2-((5-aryl-1,3,4-oxadiazol-2-yl) thio) acetate (10-15).


  • Open Access

    Amidoalkylation of heterocyclic amines by N-[5-(alkylsulfanyl)-1,3,4-thiadiazol-2-yl]- 2'-chloroacetamide and antimicrobial activity of derivatives

    by Turdibek Toshmurodov, Abdukhakim Ziyaev, Sobirdjan Sasmakov, Jaloliddin Abdurakhmanov, Mavluda Ziyaeva, Dilnoza Ismailova, Shakhnoz Azimova

    Amidoalkylation of secondary heterocyclic amines by N-[5-(alkylsulfanyl)-1,3,4-thiadiazol-2-yl]-2'-chloroacetamide resulted the new compounds 5-10 that contain 1,3,4-thiadiazole-5-thione moiety alongside pyperidine, morpholine, and cytisine fragments. In vitro screening of antimicrobial activity of synthesized compounds showed that N-[5-(amylsulfanyl)-1,3,4-thiadiazol-2-yl]-2'-morpholinacetamide exhibited an appreciable antibacterial activity against gram-negative bacteria of Escherichia coli (inhibition zone diameter of 16 mm) and gram-positive bacteria of Staphylococcus aureus and Bacillus subtilis (10-13 mm).